Medtronic received information via literature review regarding the long-term hemodynamic performance after the implant of a medtronic mechanical aortic valve.All data were collected from a single center between august 1997 and january 2004.The study population included 117 patients, 55 of which were implanted with an aortic valve and 62 which were implanted with both an aortic valve and a mitral valve.Serial numbers were not provided.The study population was predominantly female; mean age 51.2 ± 10.4 years.Among all patients adverse events included: increased gradient measurements, pannus (with and without leaflet interference) and subsequent stenosis, thromboembolism, hemorrhage, re-operation, cerebral vascular accident (cva), pneumonia, valve obstruction, regurgitation, endocarditis (haemophilus influenza) and coronary artery thrombus.Based on the available information, these events may have been attributed to a medtronic product.No additional adverse patient effects or product performance issues were reported.
|